174 related articles for article (PubMed ID: 26054847)
1. A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA.
Zhang T; Xue X; He D; Hsieh JT
Cancer Lett; 2015 Sep; 365(2):156-65. PubMed ID: 26054847
[TBL] [Abstract][Full Text] [Related]
2. A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.
Hwang DW; Son S; Jang J; Youn H; Lee S; Lee D; Lee YS; Jeong JM; Kim WJ; Lee DS
Biomaterials; 2011 Jul; 32(21):4968-75. PubMed ID: 21489620
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles.
Wadajkar AS; Menon JU; Tsai YS; Gore C; Dobin T; Gandee L; Kangasniemi K; Takahashi M; Manandhar B; Ahn JM; Hsieh JT; Nguyen KT
Biomaterials; 2013 May; 34(14):3618-25. PubMed ID: 23419645
[TBL] [Abstract][Full Text] [Related]
4. Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells.
Ekin A; Karatas OF; Culha M; Ozen M
J Gene Med; 2014; 16(11-12):331-5. PubMed ID: 25331590
[TBL] [Abstract][Full Text] [Related]
5. Formulation of glutathione responsive anti-proliferative nanoparticles from thiolated Akt1 siRNA and disulfide-crosslinked PEI for efficient anti-cancer gene therapy.
Muthiah M; Che HL; Kalash S; Jo J; Choi SY; Kim WJ; Cho CS; Lee JY; Park IK
Colloids Surf B Biointerfaces; 2015 Feb; 126():322-7. PubMed ID: 25576812
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mitogen-elicited signal transduction and growth in prostate cancer with a small peptide derived from the functional domain of DOC-2/DAB2 delivered by a unique vehicle.
Zhou J; Fan J; Hsieh JT
Cancer Res; 2006 Sep; 66(18):8954-8. PubMed ID: 16982733
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.
Ibrahim AF; Weirauch U; Thomas M; Grünweller A; Hartmann RK; Aigner A
Cancer Res; 2011 Aug; 71(15):5214-24. PubMed ID: 21690566
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
[TBL] [Abstract][Full Text] [Related]
9. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Delivery with Bioreducible Polyethylenimine as a Non-Viral Vector for Breast Cancer Gene Therapy.
Dai Y; Zhang X
Macromol Biosci; 2019 Apr; 19(4):e1800445. PubMed ID: 30614181
[TBL] [Abstract][Full Text] [Related]
11. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo.
Li D; Ping Y; Xu F; Yu H; Pan H; Huang H; Wang Q; Tang G; Li J
Biomacromolecules; 2010 Sep; 11(9):2221-9. PubMed ID: 20704346
[TBL] [Abstract][Full Text] [Related]
12. Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499.
Ando H; Asai T; Koide H; Okamoto A; Maeda N; Tomita K; Dewa T; Minamino T; Oku N
J Control Release; 2014 May; 181():32-9. PubMed ID: 24593893
[TBL] [Abstract][Full Text] [Related]
13. FGFR-targeted gene delivery mediated by supramolecular assembly between β-cyclodextrin-crosslinked PEI and redox-sensitive PEG.
Ping Y; Hu Q; Tang G; Li J
Biomaterials; 2013 Sep; 34(27):6482-94. PubMed ID: 23602276
[TBL] [Abstract][Full Text] [Related]
14. Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate.
Moffatt S; Papasakelariou C; Wiehle S; Cristiano R
Gene Ther; 2006 May; 13(9):761-72. PubMed ID: 16453011
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Delivery of miR-29b Enhances Radiosensitivity in Cervical Cancer.
Zhang T; Xue X; Peng H
Mol Ther; 2019 Jun; 27(6):1183-1194. PubMed ID: 31029553
[TBL] [Abstract][Full Text] [Related]
16. Protamine sulfate-nanodiamond hybrid nanoparticles as a vector for MiR-203 restoration in esophageal carcinoma cells.
Cao M; Deng X; Su S; Zhang F; Xiao X; Hu Q; Fu Y; Yang BB; Wu Y; Sheng W; Zeng Y
Nanoscale; 2013 Dec; 5(24):12120-5. PubMed ID: 24154605
[TBL] [Abstract][Full Text] [Related]
17. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.
Hart M; Nolte E; Wach S; Szczyrba J; Taubert H; Rau TT; Hartmann A; Grässer FA; Wullich B
Mol Cancer Res; 2014 Feb; 12(2):250-63. PubMed ID: 24337069
[TBL] [Abstract][Full Text] [Related]
18. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes.
Takeshita F; Patrawala L; Osaki M; Takahashi RU; Yamamoto Y; Kosaka N; Kawamata M; Kelnar K; Bader AG; Brown D; Ochiya T
Mol Ther; 2010 Jan; 18(1):181-7. PubMed ID: 19738602
[TBL] [Abstract][Full Text] [Related]
19. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.
Ouyang Y; Gao P; Zhu B; Chen X; Lin F; Wang X; Wei J; Zhang H
Mol Med Rep; 2015 Feb; 11(2):1435-41. PubMed ID: 25351256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
